TY  - JOUR
PY  - 2017//
TI  - Drugs and driving research in medicinal drug development
JO  - Trends in pharmacological sciences
A1  - Ramaekers, J. G.
SP  - 319
EP  - 321
VL  - 38
IS  - 4
N2  - Medicinal drugs that cause drowsiness and inattentiveness may impair driving. The FDA recently emphasized that standardized procedures for measuring drug effects on driving are needed as part of drug registration. Here, I provide an overview of a standardized on-the-road driving test that offers maximal drug sensitivity and uses a real-life outcome measure of driver impairment that is strongly associated with crash risk.<br><br>Copyright © 2017 Elsevier Ltd. All rights reserved.<p />  <p>Language: en</p>
LA  - en
SN  - 0165-6147
UR  - http://dx.doi.org/10.1016/j.tips.2017.01.006
ID  - ref1
ER  -